These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 20003838)
1. Prognostic value of CRM1 in pancreas cancer. Huang WY; Yue L; Qiu WS; Wang LW; Zhou XH; Sun YJ Clin Invest Med; 2009 Dec; 32(6):E315. PubMed ID: 20003838 [TBL] [Abstract][Full Text] [Related]
2. The expression of CRM1 is associated with prognosis in human osteosarcoma. Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467 [TBL] [Abstract][Full Text] [Related]
3. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis. Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837 [TBL] [Abstract][Full Text] [Related]
4. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer. Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054 [TBL] [Abstract][Full Text] [Related]
6. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer. Zhang Y; Dang C; Ma Q; Shimahara Y Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784 [TBL] [Abstract][Full Text] [Related]
8. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer. Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195 [TBL] [Abstract][Full Text] [Related]
10. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer. Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547 [TBL] [Abstract][Full Text] [Related]
11. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605 [TBL] [Abstract][Full Text] [Related]
12. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer. Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172 [TBL] [Abstract][Full Text] [Related]
13. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer. Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707 [TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer. Jiang WG; Douglas-Jones AG; Mansel RE Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620 [TBL] [Abstract][Full Text] [Related]
16. LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma. Liu D; Baltayan A; Naritoku WY; Barr NJ; Young LL; Chaiwun B; Tsao-Wei DD; Groshen SL; Taylor CR; Torloni H; Neville AM; Cote RJ; Imam SA Anticancer Res; 2000; 20(3A):1451-61. PubMed ID: 10928056 [TBL] [Abstract][Full Text] [Related]
17. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639 [TBL] [Abstract][Full Text] [Related]
18. HER-family gene amplification and expression in resected pancreatic cancer. te Velde EA; Franke AC; van Hillegersberg R; Elshof SM; de Weger RW; Borel Rinkes IH; van Diest PJ Eur J Surg Oncol; 2009 Oct; 35(10):1098-104. PubMed ID: 19304440 [TBL] [Abstract][Full Text] [Related]
19. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma. Hsu YC; Fu HH; Jeng YM; Lee PH; Yang SD J Clin Oncol; 2006 Aug; 24(23):3780-8. PubMed ID: 16754939 [TBL] [Abstract][Full Text] [Related]
20. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis. Rakha EA; Pinder SE; Paish EC; Robertson JF; Ellis IO J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]